M. Ishigami

发表

Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats.

S. Yamashita, Y. Matsuzawa, Toshikazu Nakamura, 2002, Journal of hepatology.

Roles of plasma lipid transfer proteins in reverse cholesterol transport.

M Ishigami, S. Yamashita, Y. Matsuzawa, 2001, Frontiers in bioscience : a journal and virtual library.

Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.

S. Yamashita, I. Komuro, M. Nishida, 2010, Journal of atherosclerosis and thrombosis.

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.

S. Yamashita, Y. Matsuzawa, T. Arai, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Enhanced expression of hepatic acyl‐coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation

S. Yamashita, T. Funahashi, Y. Matsuzawa, 1998, Hepatology.

Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.

S. Yamashita, Y. Matsuzawa, T. Arai, 2003, Atherosclerosis.

Cell-Surface Expressed Moesin-Like HDL/Apo A-I Binding Protein Is Involved in Cholesterol Efflux from Human Monocyte-derived Macrophages

S. Yamashita, Y. Matsuzawa, T. Sugimoto, 2002 .

Molecular disorders of cholesteryl ester transfer protein.

S. Yamashita, Y. Matsuzawa, T. Arai, 1996, Journal of atherosclerosis and thrombosis.

Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease.

S. Yamashita, I. Komuro, M. Nishida, 2012, Journal of atherosclerosis and thrombosis.

Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice.

S. Yamashita, I. Komuro, M. Nishida, 2010, Journal of atherosclerosis and thrombosis.

Minocycline for the treatment of Takayasu arteritis.

S. Yamashita, M. Ishigami, N. Sakai, 2005, Annals of internal medicine.

Matrix metalloproteinases as novel disease markers in Takayasu arteritis.

S. Yamashita, Y. Matsuzawa, M. Ishigami, 2004, Circulation.

Matrix Metalloproteinases as Novel Disease Markers in Takayasu Arteritis

S. Yamashita, Y. Matsuzawa, M. Ishigami, 2003 .

Morphological, cytological, and genetic analyses of the "sango" mutant with the defects in basidiocarp development in edible mushroom Pleurotus pulmonarius.

Y. Shimada, M. Ishigami, M. Ito, 2019, FEMS microbiology letters.

Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases.

S. Yamashita, I. Komuro, M. Nishida, 2012, Journal of atherosclerosis and thrombosis.

patient-oriented and epidemiological research Chylomicron remnants are increased in the postprandial state in CD36 deficiency

S. Yamashita, I. Shimomura, M. Hori, 2009 .

Microsoft Word-JBC-R1-final.docx

Kazuro Furukawa, Y. Yamauchi, K. Ueda, 2015 .

Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands.

S. Yamashita, Y. Matsuzawa, K. Ueda, 2002, Biochemical and biophysical research communications.

Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.

S. Yamashita, I. Komuro, M. Nishida, 2012, Journal of atherosclerosis and thrombosis.

Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography.

S. Yamashita, I. Komuro, Y. Monden, 2012, Metabolism: clinical and experimental.

A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.

S. Yamashita, Y. Matsuzawa, M. Yamane, 1996, Journal of lipid research.

Very High Density Lipoproteins Induced by Plasma Cholesteryl Ester Transfer Protein (CETP) Have a Potent Antiatherogenic Function a

S. Yamashita, Y. Matsuzawa, T. Arai, 1994, Annals of the New York Academy of Sciences.

High‐density lipoproteins from probucol‐treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low‐density lipoproteins

S. Yamashita, Y. Matsuzawa, T. Arai, 1997, European journal of clinical investigation.

Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects.

S. Yamashita, M. Menju, T. Arai, 1995, Atherosclerosis.

Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia.

S. Yamashita, T. Funahashi, M. Menju, 1993, Atherosclerosis.

Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins.

S. Yamashita, Y. Matsuzawa, T. Arai, 1994, Journal of biochemistry.

Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients

S. Yamashita, M. Ishigami, N. Sakai, 2007, Molecular and Cellular Biochemistry.

Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.

S. Yamashita, Y. Tomiyama, M. Ishigami, 1995, The Journal of clinical investigation.

Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism.

S. Yamashita, I. Komuro, M. Nishida, 2012, Clinica chimica acta; international journal of clinical chemistry.

Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency.

M. Hayden, S. Yamashita, Y. Matsuzawa, 2002, Biochemical and biophysical research communications.

Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism.

S. Yamashita, Y. Matsuzawa, M. Ishigami, 2003, Diabetes care.

Development of a homogeneous assay to measure remnant lipoprotein cholesterol.

S. Yamashita, T. Irie, M. Ishigami, 2007, Clinical chemistry.

Remnant lipoprotein-cholesterol is a predictive biomarker for large artery atherosclerosis in apparently healthy women: usefulness as a parameter for annual health examinations

S. Yamashita, M. Nishida, T. Moriyama, 2011, Annals of clinical biochemistry.

Interferon α induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C

S. Kihara, S. Yamashita, Y. Matsuzawa, 1997, Hepatology.

Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations.

S. Yamashita, I. Shimomura, N. Sakane, 2009, Journal of atherosclerosis and thrombosis.

Molecular genetics of plasma cholesteryl ester transfer protein.

S. Yamashita, Y. Matsuzawa, T. Arai, 1997, Current opinion in lipidology.

Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages.

S. Kihara, S. Yamashita, I. Shimomura, 2008, Biochemical and biophysical research communications.

Correlation of fasting serum apolipoprotein B‐48 with coronary artery disease prevalence

S. Yamashita, I. Komuro, M. Nishida, 2012, European journal of clinical investigation.

Apolipoprotein B-48 to triglyceride ratio is a novel and useful marker for detection of type III hyperlipidemia after antihyperlipidemic intervention.

S. Yamashita, I. Komuro, M. Nishida, 2012, Journal of atherosclerosis and thrombosis.

Adiponectin deficiency suppresses ABCA1 expression and ApoA‐I synthesis in the liver

S. Kihara, S. Yamashita, I. Shimomura, 2007 .

Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia--a possible pathogenesis of necrobiotic xanthogranuloma.

S. Yamashita, T. Funahashi, Y. Matsuzawa, 1999, Atherosclerosis.

Fasting serum apolipoprotein B-48 can be a marker of postprandial hyperlipidemia.

S. Yamashita, I. Komuro, M. Nishida, 2011, Journal of atherosclerosis and thrombosis.

Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins.

S. Yamashita, Y. Matsuzawa, M. Ishigami, 2003, Atherosclerosis.

Plasma cholesteryl ester transfer protein (CETP) induces very high density lipoproteins (VHDL) with a potent anti-atherogenic function

S. Yamashita, Y. Matsuzawa, T. Arai, 1994 .

A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.

S. Kihara, T. Funahashi, I. Shimomura, 2010, Internal medicine.

Evaluation of a homogeneous assay for measuring LDL-cholesterol in hyperlipidemic serum specimens.

S. Yamashita, I. Shimomura, M. Nishida, 2008, Journal of atherosclerosis and thrombosis.

Temporary sequestration of cholesterol and phosphatidylcholine within extracellular domains of ABCA1 during nascent HDL generation

K. Ueda, N. Kioka, M. Ishigami, 2018, Scientific Reports.

Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages

S. Kihara, S. Yamashita, T. Funahashi, 2001, Circulation.

Interferon Alpha Induces Disorder of Lipid Metabolism by Lowering Postheparin Lipases and Cholesteryl Ester Transfer Protein Activities in Patients With Chronic Hepatitis C

S. Kihara, S. Yamashita, T. Arai, 1998 .

The Role of Microsomal Triglyceride Transfer Protein (MTP) in the Mechanism of Hyperlipidemia Under Overnutrition State

S. Yamashita, T. Funahashi, M. Ishigami, 2011 .

A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.

M. Ishigami, T. Minakata, T. Yamamura, 2011, Journal of atherosclerosis and thrombosis.

Apolipoprotein E Inhibits Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Migration and Proliferation by Suppressing Signal Transduction and Preventing Cell Entry to G1 Phase*

D. Hui, M. Ishigami, D. Swertfeger, 1998, The Journal of Biological Chemistry.

Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.

S. Kihara, S. Yamashita, I. Shimomura, 2008, FEBS letters.

Senescent phenotypes of skin fibroblasts from patients with Tangier disease.

S. Yamashita, I. Shimomura, M. Hori, 2007, Biochemical and biophysical research communications.

Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E Suita).

S. Kihara, S. Yamashita, T. Funahashi, 1997, Atherosclerosis.

Impaired efflux of cholesterol from aged cells and its molecular mechanism: A basis for age‐related enhancement of atherosclerosis

S. Yamashita, I. Shimomura, M. Nishida, 2007 .

Retarded Intracellular Lipid Transport Associated With Reduced Expression of Cdc42, a Member of Rho-GTPases, in Human Aged Skin Fibroblasts: A Possible Function of Cdc42 in Mediating Intracellular Lipid Transport

S. Yamashita, Y. Matsuzawa, M. Ishigami, 2002, Arteriosclerosis, thrombosis, and vascular biology.

ATPase activity of nucleotide binding domains of human MDR3 in the context of MDR1.

K. Ueda, N. Kioka, M. Ishigami, 2013, Biochimica et biophysica acta.

Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells.

S. Kihara, S. Yamashita, Y. Matsuzawa, 1998, Circulation.

Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography

S. Yamashita, Y. Matsuzawa, M. Ishigami, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Novel combined GPIHBP1 mutations in a patient with hypertriglyceridemia associated with CAD.

Y. Matsuzawa, Hiroyasu Yamamoto, M. Ishigami, 2013, Journal of atherosclerosis and thrombosis.

Deficiency in the Lipid Exporter ABCA1 Impairs Retrograde Sterol Movement and Disrupts Sterol Sensing at the Endoplasmic Reticulum*♦

Y. Yamauchi, S. Yokoyama, K. Ueda, 2015, The Journal of Biological Chemistry.

Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver.

S. Kihara, S. Yamashita, I. Shimomura, 2007, Biochemical and biophysical research communications.

Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency

S. Yamashita, T. Funahashi, Y. Matsuzawa, 1995, European journal of clinical investigation.

Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels.

S. Yamashita, I. Komuro, Y. Monden, 2011, Atherosclerosis.

Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis

M. Takahashi, S. Kihara, S. Yamashita, 2003, European journal of clinical investigation.

Effects of A Novel Acat Inhibitor, F-1394, on the Progression and Regression of Atherosclerotic Lesions in the Aorta of Cholesterol-Fed Rabbits

S. Yamashita, Y. Matsuzawa, A. Islam, 1996 .

ABCB4 exports phosphatidylcholine in a sphingomyelin-dependent manner[S]

K. Ueda, N. Kioka, H. Arai, 2015, Journal of Lipid Research.

Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity.

S. Yamashita, Y. Matsuzawa, M. Yamane, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.

S. Kihara, S. Yamashita, Y. Matsuzawa, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Differential reactivities of four homogeneous assays for LDL-cholesterol in serum to intermediate-density lipoproteins and small dense LDL: comparisons with the Friedewald equation.

S. Yamashita, M. Nishida, M. Ishigami, 2009, Clinica chimica acta; international journal of clinical chemistry.

Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport.

S. Yamashita, Y. Matsuzawa, M. Nishida, 2001, Atherosclerosis.

Matrix Metalloproteinases as Novel Disease Markers in Takayasu Arteritis

S. Yamashita, Y. Matsuzawa, M. Ishigami, 2003, Circulation.

Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia

S. Yamashita, M. Nishida, M. Ishigami, 2009, European journal of clinical investigation.

patient-oriented and epidemiological research Chylomicron remnants are increased in the postprandial state in CD36 deficiency

M. Nishida, M. Ishigami, K. Hirano, 2009 .

Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease.

S. Yamashita, I. Komuro, M. Nishida, 2012, Journal of atherosclerosis and thrombosis.

M.584 Matrix metalloproteinases as novel disease markers in takayasu arteritis

S. Yamashita, Y. Matsuzawa, M. Ishigami, 2004 .